SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001567619-22-021344
Filing Date
2022-12-06
Accepted
2022-12-06 15:19:25
Documents
1
Period of Report
2022-12-02

Document Format Files

Seq Description Document Type Size
1 FORM 4 doc1.html 4  
1 FORM 4 doc1.xml 4 7577
  Complete submission text file 0001567619-22-021344.txt   10109
Mailing Address 301 CARLSON PARKWAY SUITE 210 MINNEAPOLIS MN 55305
Business Address 301 CARLSON PARKWAY SUITE 210 MINNEAPOLIS MN 55305 (763) 496-5454
DiaMedica Therapeutics Inc. (Issuer) CIK: 0001401040 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O EQT PARTNERS AB BOX 16509 STOCKHOLM V7 103 27
Business Address C/O EQT PARTNERS AB BOX 16509 STOCKHOLM V7 103 27 46 70 514 21 94
TomEnterprise AB (Reporting) CIK: 0001887435 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36291 | Film No.: 221447495

Mailing Address TOMENTERPRISE AB BOX 5322 STOCKHOLM V7 102 47
Business Address
Von Koch Thomas (Reporting) CIK: 0001938915 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36291 | Film No.: 221447496

Mailing Address C/O KINKON AB BIBLIOTEKSGATAN 25 STOCKHOLM V8 11435
Business Address C/O KINKON AB BIBLIOTEKSGATAN 25 STOCKHOLM V8 11435 46705142194
TomEqt Private AB (Reporting) CIK: 0001956782 (see all company filings)

State of Incorp.: V8 | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-36291 | Film No.: 221447494